16
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia

, &
Pages 73-81 | Received 30 Aug 1987, Published online: 08 Jul 2009

References

  • Green P HR, Glickman R M, Saudek C D, Blum C B, Tall A R. Human intestinal lipoproteins: studies in chyluric subjects. J Clin Invest 1979; 64: 233–42
  • Scow R O, Blanchette-Mackie E J, Smith L C. Role of capillary endothelium in the clearance of chylomicrons: a model for lipid transport from blood by lateral diffusion in cell membranes. Circ Res 1976; 39: 149–62
  • Redgrave T G. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest 1970; 49: 465–71
  • Sherill B C, Innerarity T L, Mahley R W. Rapid hepatic clearance of canine lipoproteins containing only the E apoprotein by a high affinity receptor (identity with the chylomicron remnant transport process). J Biol Chem 1980; 255: 1804–7
  • Shelburne F, Hanks J, Meyers W, Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in rat. J Clin Invest 1980; 65: 652–8
  • Windier E, Chao Y, Havel R J. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipo-protein E and individual C apoproteins. J Biol Chem 1980; 255: 8303–7
  • La Rosa J C, Levy R I, Herbert P, Lux S E, Fredrickson D S. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun 1970; 41: 57–62
  • Brown W V, Baginsky M L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 1972; 46: 375–82
  • Schaefer E J, Eisenberg S, Levy R I. Lipoprotein apoprotein metabolism. J Lipid Res 1978; 19: 667–87
  • Havel R J, Kane J P, Kashyap M L. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 1973; 52: 32–8
  • Soutar A K, Garner C W, Baker H N, et al. Effect of the human plasma lipoproteins and the phosphatidylcholine acyl donor on the activity of lecithinxholesterol acyltransferase. Biochemistry 1975; 14: 3057–64
  • Carlson K. Lipoprotein fractionation. J Clin Path 1973; 26(5)32–7
  • Zlatkis A, Zak B, Boyle J. A new method for the direct determination of serum cholesterol. J Lab Clin Med 1973; 41: 486–92
  • Fletcher M J. A colorimetric method for estimating serum triglycerides. Clin Chim Acta 1968; 22: 393–7
  • Holmquist L. Quantitation of human serum very low density apolipoproteins C-I, C-II, C-III and E by enzyme immunoassay. J Immunol Meth 1980; 34: 243–51
  • Holmquist L. Quantitation of human serum apolipoprotein B by enzyme immunoassay. Clin Chim Acta 1982; 121: 327–36
  • Carlson L A, Holmquist L. Concentrations of apolipoproteins B, C-I, C-II, C-III and E in sera from normal men and their relation to serum lipoprotein levels. Clin Chim Acta 1982; 124: 163–8
  • Snedecor G W, Cochran W G. Statistical Methods, 7th edn. The Iowa State University Press, Ames, Iowa 1980
  • Angervall G. On the fat tolerance test. Acta Med Scand 1964; 176(suppl. 424)1–84
  • Herbert P N, Assmann G, Gotto A M, Jr, Fredricson D S. The Metabolic Basis of Inherited Disease. McGraw-Hill, New York 1982; 589–621
  • Kashyap M L, Barnhart R L, Srivastava L S. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects. Am J Clin Nutr 1983; 37: 233–43
  • Schaefer E J, Jenkins L L, Brewer H B, Jr. Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Commun 1978; 80: 405–12
  • Havel R J, Kotite L, Vigne J L, et al. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J Clin Invest 1980; 66: 1351–62
  • Kushwaha R S, Hazzard W R, Wahl P W, Hoover J J. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein E immunoassay. Ann Intern Med 1977; 87: 509–16
  • Utermann G, Jaenshke M, Mangel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very low density lipoproteins. FEBS Lett 1975; 56: 352–5
  • Annuzzi G, Carlson L A, Holmquist L. Absolute decrease of serum apolipoproteins C-II and C-III during alimentary lipemia in humans. Giornale Arteriosclerosi 1985, Suppl. 1, 3 Nuova Serie(abstr.)
  • Barr S I, Kottke B A, Mao S JT. Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: Comparison of meals containing corn oil and medium-chain triglyceride oil. Metabolism 1985; 34(11)983–92
  • Berman M, Hall M, Levy R I, et al. Metabolism in apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteinemic subjects. J Lipid Res 1978; 19: 38–56
  • Redgrave T G, Carlson L A. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 1979; 20: 217–29
  • Kane J P. Apolipoprotein B: Structural and metabolic heterogeneity. Ann Rev Physiol 1983; 45: 637–50
  • Teng B, Thompson G R, Sniderman A D, Forte T M, Krauss R M, Kwiterovich P O. Composition and distribution of low density lipoprotein fractions in hyperapo-β- lipoproteinemia, normolipidemia and familial hypercholesterolemia. Proc Nat Acad Sci, USA 1983; 80: 6662–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.